A Study of Olaratumab in Soft Tissue Sarcoma

Clinical trial NCT01185964 · COMPLETED

Trial details

NCT number: NCT01185964
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Sarcoma, Soft Tissue

Start date: 2010-10-01
Primary completion: 2014-08-01
Enrollment: 148

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.